Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces

The Journal of Antimicrobial Chemotherapy
C ChuardD P Lew

Abstract

The frequency of small colony variants of staphylococci associated with persistent, antibiotic resistant and relapsing infections is probably underestimated. These variants demonstrate decreased metabolism, leading to slow growth, increased resistance to cell-wall-active antibiotics, and decreased uptake of aminoglycoside antibiotics. This altered phenotype arises from defects in menadione and haemin biosynthesis resulting in impaired electron transport and decreased ATP concentrations. The recent acquisition of a stable small colony variant (SCV strain JB1), generated from strain 6850 of Staphylococcus aureus, allowed us to study the susceptibilities to antibiotic killing of parent and variant strains. Because differences in susceptibilities have been found between unattached and surface-adherent organisms, we tested both strains in solid and fluid-phase assays. Suspensions of SCV strain JB1 exposed to 8 x MIC of either oxacillin, vancomycin or fleroxacin, exhibited lower reductions in viable counts than the parent strain 6850, especially when high bacterial concentrations (1-2 x 10(7) cfu/mL) of either strain were tested. Susceptibility to antibiotic killing of bacteria attached to fibronectin-coated coverslips was markedly i...Continue Reading

Citations

Jul 27, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P VaudauxA Renzoni
Mar 18, 2000·International Journal of Antimicrobial Agents·P J McNamara, R A Proctor
Mar 17, 2006·Nature Reviews. Microbiology·Richard A ProctorGeorg Peters
May 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Longzhu CuiKeiichi Hiramatsu
Jul 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A Proctor
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Teresa SpanuGiovanni Fadda
Sep 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Parham SendiWerner Zimmerli
Mar 15, 2013·The Journal of Antimicrobial Chemotherapy·Laetitia G GarciaFrançoise Van Bambeke
May 2, 2012·Antimicrobial Agents and Chemotherapy·Steven D PodosMichael J Pucci
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Kazuko TaniguchiYoichiro Miyake
Oct 28, 2005·Antimicrobial Agents and Chemotherapy·Zhifang XieEric J Rubin
Mar 25, 2005·Acta Orthopaedica·Daniëlle NeutHenk J Busscher
Mar 5, 2015·Pathogens·Louise Cullen, Siobhán McClean
Oct 5, 2011·International Journal of Medical Microbiology : IJMM·Sabine GröbnerBerit Schulte
Jul 13, 2005·Cellular Microbiology·Bettina Haslinger-LöfflerBhanu Sinha
Feb 14, 2004·Clinical Otolaryngology and Allied Sciences·N FergieJ P Birchall
Aug 31, 2007·Journal of Biomedical Materials Research. Part a·Corine A N BroekhuizenSebastian A J Zaat
Oct 19, 2006·The Journal of Hospital Infection·D Lindsay, A von Holy
May 3, 2006·Injury·Pierre Vaudaux, Daniel P Lew
Aug 15, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·R A Proctor, A von Humboldt
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·P Vaudaux
Apr 9, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Server YagciGulsen Hascelik
Apr 9, 2013·Virulence·Sarah Schmidt Grant, Deborah T Hung
Apr 19, 2015·BMC Genomics·Marina SantiagoTimothy C Meredith
Jul 22, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Geraint B RogersGerd Döring
Jun 21, 2005·FEMS Immunology and Medical Microbiology·François MalouinNorris E Allen
Jan 28, 2017·Trends in Molecular Medicine·Sanjeev Mariathasan, Man-Wah Tan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Richard A Proctor, Georg Peters
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Christof von EiffGeorg Peters
© 2021 Meta ULC. All rights reserved